# NetEase, Inc.: financial statements, quarterly

NTES · Nasdaq · CIK 1110646 · [Technology](/sectors/technology.md)

Pages: [Overview](/companies/ntes.md) · [Financials](/companies/ntes/financials.md) · [Filings](/companies/ntes/filings.md) · [Insiders](/companies/ntes/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ntes/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2014 (2014-12-31) | FY2015 (2015-12-31) | FY2016 (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001104659-16-113375.md) | [0.9](/filings/0001104659-17-025196.md) | [0.8](/filings/0001104659-18-025392.md) | [0.4](/filings/0001104659-18-025392.md) | [0.8](/filings/0001104659-19-023833.md) | [0.5](/filings/0001104659-20-052796.md) | [1.4](/filings/0001104659-21-055902.md) | [2.3](/filings/0001104659-22-052206.md) | [3.6](/filings/0001104659-23-050589.md) | [3.0](/filings/0001104659-24-051449.md) | [7.0](/filings/0001410578-25-000728.md) | [6.7](/filings/0001104659-26-043468.md) |
| Current assets | $bn | [4.5](/filings/0001104659-15-030142.md) | [5.3](/filings/0001104659-16-113375.md) | [7.2](/filings/0001104659-17-025196.md) | [9.5](/filings/0001104659-18-025392.md) | [10.0](/filings/0001104659-19-023833.md) | [12.2](/filings/0001104659-20-052796.md) | [16.5](/filings/0001104659-21-055902.md) | [17.8](/filings/0001104659-22-052206.md) | [19.1](/filings/0001104659-23-050589.md) | [20.1](/filings/0001104659-24-051449.md) | [21.0](/filings/0001410578-25-000728.md) | [25.8](/filings/0001104659-26-043468.md) |
| Total assets | $bn | [4.9](/filings/0001104659-15-030142.md) | [6.4](/filings/0001104659-16-113375.md) | [8.4](/filings/0001104659-17-025196.md) | [10.9](/filings/0001104659-18-025392.md) | [12.6](/filings/0001104659-19-023833.md) | [16.1](/filings/0001104659-20-052796.md) | [21.7](/filings/0001104659-21-055902.md) | [24.1](/filings/0001104659-22-052206.md) | [25.0](/filings/0001104659-23-050589.md) | [26.2](/filings/0001104659-24-051449.md) | [26.9](/filings/0001410578-25-000728.md) | [31.7](/filings/0001104659-26-043468.md) |
| Current liabilities | $bn | [1.1](/filings/0001104659-15-030142.md) | [1.8](/filings/0001104659-16-113375.md) | [2.8](/filings/0001104659-17-025196.md) | [3.7](/filings/0001104659-18-025392.md) | [5.1](/filings/0001104659-19-023833.md) | [5.5](/filings/0001104659-20-052796.md) | [7.2](/filings/0001104659-21-055902.md) | [7.9](/filings/0001104659-22-052206.md) | [8.2](/filings/0001104659-23-050589.md) | [7.6](/filings/0001104659-24-051449.md) | [6.8](/filings/0001410578-25-000728.md) | [7.5](/filings/0001104659-26-043468.md) |
| Total liabilities | $bn | [1.1](/filings/0001104659-15-030142.md) | [1.8](/filings/0001104659-16-113375.md) | [2.8](/filings/0001104659-17-025196.md) | [3.7](/filings/0001104659-18-025392.md) | [5.2](/filings/0001104659-19-023833.md) | [5.6](/filings/0001104659-20-052796.md) | [7.4](/filings/0001104659-21-055902.md) | [8.5](/filings/0001104659-22-052206.md) | [9.3](/filings/0001104659-23-050589.md) | [8.1](/filings/0001104659-24-051449.md) | [7.3](/filings/0001410578-25-000728.md) | [8.1](/filings/0001104659-26-043468.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.2](/filings/0001104659-22-052206.md) | [0.5](/filings/0001104659-23-050589.md) | [0.1](/filings/0001104659-24-051449.md) | [0.1](/filings/0001410578-25-000728.md) | not reported |
| Shareholders' equity | $bn | [3.8](/filings/0001104659-15-030142.md) | [4.5](/filings/0001104659-16-113375.md) | [5.5](/filings/0001104659-17-025196.md) | [7.0](/filings/0001104659-18-025392.md) | [6.6](/filings/0001104659-19-023833.md) | [8.8](/filings/0001104659-20-052796.md) | [12.6](/filings/0001104659-21-055902.md) | [15.0](/filings/0001104659-22-052206.md) | [15.2](/filings/0001104659-23-050589.md) | [17.5](/filings/0001104659-24-051449.md) | [19.0](/filings/0001410578-25-000728.md) | [22.9](/filings/0001104659-26-043468.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 3,192,111,251 at 2025-12-31, from the cover of the [20-F filed 2026-04-15](/filings/0001104659-26-043468.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.